GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly development in how we handle diabetes mellitus . These new medications work by mimicking the body’s natural GLP-1 substance https://cruxbookmarks.com/story21782658/glp-1-a-significant-breakthrough-in-diabetes-treatment